Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
FDA launches strategy to strengthen infant formula supply chain
The FDA's latest long-term strategy on the U.S. infant formula market addresses supply chain vulnerabilities with enhanced oversight, collaboration and market diversification.
-
FDA draft guidance targets racial bias in pulse oximeters
On Jan. 6, 2025, the FDA issued a draft guidance to tackle racial bias in pulse oximeters, focusing on improving accuracy and performance to ensure equitable healthcare technology.
-
Respiratory disease statistics show increasing infection rates
Respiratory disease statistics found on the CDC's Respiratory Illness Data Channel have shown rising rates of emergency department visits and wastewater viral activity levels.
-
FDA approves Zepbound for obstructive sleep apnea
The FDA has expanded Zepbound's indications, allowing its use beyond weight management to treat moderate-to-severe obstructive sleep apnea in patients with obesity.
-
AMA's top 10 health recommendations for 2025
As the new year approaches, the AMA has released 10 recommendations aimed at helping individuals achieve meaningful and lasting health improvements in 2025 and beyond.
-
USPSTF proposes guidelines for cervical cancer screening
With the advent of new self-collection methods for HPV testing, the USPSTF has proposed draft guidelines for cervical cancer screening that include patient-collected HPV tests.
Features
-
Modernizing pharma manufacturing with AMT designation
The FDA's AMT Designation Program seeks to transform pharmaceutical manufacturing by improving drug quality, enhancing supply chain resilience and accelerating drug development timelines.
-
Understanding biomarker validation, qualification challenges
Biomarker validation and qualification challenges might include reproducibility, standardization, regulation, diversity, time, economics and clinical implementation.
-
Analyzing therapeutic psychedelics: Opportunities, challenges
Experts at the 2024 WMIF discuss the challenges and opportunities associated with therapeutic psychedelics, including cost, access, continued innovation and patient management.
-
Advancing continuous manufacturing with FDA support
Continuous manufacturing is transforming pharmaceuticals with FDA support, bringing faster production, cost savings and improved quality to the industry.